Search research articles
Contact Us
Filters
Showing results (141-150 of 154) with videos related to
Page
of 16
Sort By:
Blood Advances
|
February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 12, 2025
Diagnostic accuracy of tongue swab testing in persons with sputum Xpert Ultra Trace results
Adrienne E Shapiro, Ronit R Dalmat, Job Mukwatamundu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2020
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant
Scott R Solomon, Andrew St Martin, Mei-Jie Zhang, et al.
The Lancet. Oncology
|
December 13, 2021
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Caron A Jacobson, Julio C Chavez, Alison R Sehgal, et al.
Neuro-Oncology
|
January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Kristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
Julio C Chavez, Francine M Foss, Basem M William, et al.
Blood Advances
|
September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
Celalettin Ustun, Soyoung Kim, Min Chen, et al.
Transplantation
|
June 23, 2025
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study
Meera Gupta, Michelle L Schoettler, Gabriel Orozco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 154) with videos related to
Sort By:
Page
of 16
Blood Advances
|
February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 12, 2025
Diagnostic accuracy of tongue swab testing in persons with sputum Xpert Ultra Trace results
Adrienne E Shapiro, Ronit R Dalmat, Job Mukwatamundu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2020
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant
Scott R Solomon, Andrew St Martin, Mei-Jie Zhang, et al.
The Lancet. Oncology
|
December 13, 2021
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Caron A Jacobson, Julio C Chavez, Alison R Sehgal, et al.
Neuro-Oncology
|
January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Kristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
Julio C Chavez, Francine M Foss, Basem M William, et al.
Blood Advances
|
September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
Celalettin Ustun, Soyoung Kim, Min Chen, et al.
Transplantation
|
June 23, 2025
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study
Meera Gupta, Michelle L Schoettler, Gabriel Orozco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Page
of 16